EUCTR2019-003028-19-IT
Active, not recruiting
Phase 1
Clinical-instrumental definition of the phenotypic spectrum, response to treatment and natural history in Pearson and Kearns-Sayre syndrome - PS_KSS
IRCCS, OSPEDALE PEDIATRICO BAMBINO GESÙ DI ROMA0 sites27 target enrollmentMay 24, 2021
ConditionsPearson and Kearns-Sayre syndrome.MedDRA version: 20.1Level: PTClassification code 10058799Term: Mitochondrial encephalomyopathySystem Organ Class: 10010331 - Congenital, familial and genetic disordersMedDRA version: 20.1Level: PTClassification code 10051403Term: Mitochondrial DNA deletionSystem Organ Class: 10010331 - Congenital, familial and genetic disordersMedDRA version: 20.0Level: LLTClassification code 10074070Term: Mitochondrial encephalopathySystem Organ Class: 10010331 - Congenital, familial and genetic disordersTherapeutic area: Diseases [C] - Nutritional and Metabolic Diseases [C18]
DrugsLederfolin
Overview
- Phase
- Phase 1
- Intervention
- Not specified
- Conditions
- Pearson and Kearns-Sayre syndrome.
- Sponsor
- IRCCS, OSPEDALE PEDIATRICO BAMBINO GESÙ DI ROMA
- Enrollment
- 27
- Status
- Active, not recruiting
- Last Updated
- 4 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Diagnosis of PS/KSS syndromes with confirmed genetic mutations associated PS/KSS syndromes. Diagnosis will be performed on review of muscle/skin biopsies, presence of mtDNa deletion on mtDNA samples from peripheral blood lymphocytes, urinary tract cells in urine, or muscle (Southern blot, Long PCR, MLPA), quantification of mtDNA deletions by Quantitative PCR. If genetic confirmation and quantification of mtDNA deletion is not available, it will performed at screening
- •Newcastle Pediatric Mitochondrial Disease Scale score of \=15 and \= 60 on sections 1\-3
- •Evidence of disease progression within 12 months preceeding the screening either by NPMDS score or documented evidence of neurologic deterioration
- •Availability of pre\-enrollment brain MRI that confirms the characteristic basal ganglia damage or leukoencephalopathy of PS/KSS syndromes performed within 6 months prior to screening (if brain MRI/MRS is not available, it will performed at screening)
- •Male or female age 1 to 25 years
- •Patient or patient’s guardian able to consent and comply with protocol requirements
- •Are the trial subjects under 18? yes
- •Number of subjects for this age range:
- •F.1\.2 Adults (18\-64 years) yes
- •F.1\.2\.1 Number of subjects for this age range 9
Exclusion Criteria
- •Allergy to folinic acid
- •Clinical history of bleeding or abnormal baseline PT, PTT (or aPTT) or INR
- •Pernicious Anemia,
- •Hereditary fructose intolerance, glucose / galactose malabsorption syndrome or sucrase\-isomaltase deficiency,
- •Not\-mitochondrial Diabetes
- •Concomitant use of methotrexate
- •Clinically significant disease, such as, but not limited to, hepatitis C virus (HCV) / human Immunodeficiency virus (HIV) / hepatitis B virus (HBV) / Cancer, that precludes study participation
- •Diagnosis of any other concurrent inborn error of metabolism
- •Previous tracheostomy
- •Ventilator dependent or use of noninvasive ventilatory support within one month of enrollment
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Not Applicable
Analysis of clinical,histopathological and immunological features of bullous pemphigoid induced by dipeptidyl peptidase -4 inhibitorsCTRI/2020/08/027157Indian association of DermatologistsVenereologists and Leprologists
Recruiting
Not Applicable
Improved characterisation of the clinical phenotype of Hereditary Motor Sensory Neuropathy of neuronal type with onset of symptoms in early childhood, especially with respect to disease progression with age and the incidence of such complications as foot deformity, contractures, scoliosis and respiratory involvement - an observational study.Hereditary motor sensory neuropathy of neuronal type with onset in early childhoodHuman Genetics and Inherited Disorders - Other human genetics and inherited disordersNeurological - Other neurological disordersACTRN12605000128695The Children's Hospital at Westmead20
Completed
Not Applicable
Study on Effectiveness and Safety of Intracorporeal Anastomosis in Laparoscopic ColectomyColorectal cancerJPRN-UMIN000050592ational Cancer Center325
Completed
Not Applicable
Clinical manifestation and risk factors associated with remission in patients with filamentary keratitisKCT0004866Ewha Womans University Medical Center116
Recruiting
Not Applicable
arrow band imaging in head and neck cancer- All adult patients with a suspected malignant mucosal lesion of the upper aerodigestive tract - Patients with benign upper aerodigestive tract lesionsNL-OMON27129niversity Medical Center Groningen600